Cristofori Fernanda, Castellaneta Stefania, Dargenio Costantino, Paulucci Leonardo, Lagrasta Giovanni, Barone Michele, Francavilla Ruggiero, Dargenio Vanessa Nadia
Interdisciplinary Department of Medicine, University of Bari Aldo Moro, Pediatria "Bruno Trambusti", Ospedale Pediatrico Giovanni XXIII, Bari, Italy.
Unit of Pediatrics-Neonatology-Cystic Fibrosis, 'G. Tatarella' Hospital, Cerignola, Italia.
Expert Rev Gastroenterol Hepatol. 2025 Jun 23:1-21. doi: 10.1080/17474124.2025.2519160.
Functional gastrointestinal disorders (FGIDs) and inflammatory bowel diseases (IBD) present significant challenges for both pediatric and adult populations. The low FODMAP diet (LFD) has gained prominence as an evidence-based dietary intervention, offering symptom relief for abdominal pain, bloating, and altered bowel habits. However, concerns about adherence, nutritional adequacy, and long-term safety remain critical, particularly in pediatric populations.
This narrative review examines the nature and physiological impact of FODMAPs, focusing on the practical application of the low-FODMAP diet (LFD) in adults and pediatric gastroenterology. Particular attention is given to emerging insights into its impact on gut microbiota and long-term safety.
While LFD effectively alleviates symptoms in FGIDs and functional symptoms in IBD, its restrictive nature demands professional supervision to mitigate nutritional risks. For pediatric patients, adherence and reintroduction protocols require optimization. Further research into personalized dietary approaches and microbiome-targeted strategies could enhance the clinical utility of the LFD, ensuring its long-term safety and efficacy for diverse patient groups.
Many people, both children and adults, experience stomach and bowel problems like pain, bloating, and changes in bowel habits. These symptoms are common in conditions such as functional gastrointestinal disorders (FGIDs). One dietary approach, called the low FODMAP diet (LFD), has been shown to help reduce these symptoms. The diet limits certain types of carbohydrates, called FODMAPs, which are found in foods like some fruits, vegetables, dairy products, and grains. These carbohydrates can ferment in the gut, causing discomfort in some people.This review looks at how the LFD works, its effectiveness, and its safety. Research shows that the diet can reduce symptoms for many people, particularly those with FGIDs, and it can also help people with IBD who experience additional gut symptoms even when their disease is not active. However, the LFD is a restrictive diet, which means it may be hard to follow and could lead to nutritional issues, especially in children, without professional support.The review also explores how the LFD affects gut bacteria, as the diet can reduce some beneficial bacteria. To make the diet more practical, researchers recommend working with dietitians to ensure it is followed safely and effectively. More studies are needed to understand the long-term impact of the LFD and how it can be adapted to different people's needs.This summary aims to explain the benefits and challenges of the LFD, highlighting the importance of professional guidance and further research to improve its use.
功能性胃肠疾病(FGIDs)和炎症性肠病(IBD)对儿童和成人都构成了重大挑战。低FODMAP饮食(LFD)作为一种循证饮食干预方法已受到关注,可缓解腹痛、腹胀和排便习惯改变等症状。然而,对其依从性、营养充足性和长期安全性的担忧仍然至关重要,尤其是在儿科人群中。
本叙述性综述探讨了FODMAPs的性质和生理影响,重点关注低FODMAP饮食(LFD)在成人和儿科胃肠病学中的实际应用。特别关注了其对肠道微生物群影响和长期安全性的新见解。
虽然LFD能有效缓解FGIDs的症状以及IBD的功能性症状,但其限制性要求专业监督以降低营养风险。对于儿科患者,需要优化依从性和重新引入方案。对个性化饮食方法和针对微生物群的策略的进一步研究可以提高LFD的临床效用,确保其对不同患者群体的长期安全性和有效性。
许多儿童和成人都经历过胃痛和肠道问题,如疼痛、腹胀和排便习惯改变。这些症状在功能性胃肠疾病(FGIDs)等疾病中很常见。一种名为低FODMAP饮食(LFD)的饮食方法已被证明有助于减轻这些症状。该饮食限制了某些类型的碳水化合物,即FODMAPs,它们存在于一些水果、蔬菜、乳制品和谷物等食物中。这些碳水化合物会在肠道中发酵,使一些人感到不适。本综述探讨了LFD的作用方式、有效性和安全性。研究表明,这种饮食可以减轻许多人的症状,尤其是那些患有FGIDs的人,它还可以帮助患有IBD的人,即使在疾病不活跃时,这些人也会出现额外的肠道症状。然而,LFD是一种限制性饮食,这意味着如果没有专业支持可能很难遵循,并且可能导致营养问题,尤其是在儿童中。该综述还探讨了LFD如何影响肠道细菌,因为这种饮食会减少一些有益细菌。为了使这种饮食更实用,研究人员建议与营养师合作,以确保安全有效地遵循。需要更多的研究来了解LFD的长期影响以及如何根据不同人的需求进行调整。本总结旨在解释LFD的益处和挑战,强调专业指导和进一步研究以改进其应用的重要性。